Viewing Study NCT06614153



Ignite Creation Date: 2024-10-25 @ 7:50 PM
Last Modification Date: 2024-10-26 @ 3:41 PM
Study NCT ID: NCT06614153
Status: COMPLETED
Last Update Posted: None
First Post: 2024-09-23

Brief Title: PharmacokineticsPharmacodynamicsEfficacy and Safety of HRG2010 in Parkinsons Disease Patients With Motor Fluctuations
Sponsor: None
Organization: None

Study Overview

Official Title: A Randomized Open-label Controlled Single-dose Multiple-dose Phase II Study to Evaluate the PharmacokineticsPharmacodynamicsEfficacy and Safety of HRG2010 in Parkinsons Disease Patients With Motor Fluctuations
Status: COMPLETED
Status Verified Date: 2024-09
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: No
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The study is a multicenter randomized open-label active-controlled Phase II clinical study The aim of this trial is to evaluated the pharmacokinetics pharmacodynamicsefficacy and assessed the safety of HRG2010 compared with a sustained-release cabridopa-levodopa formulation in Parkinsons Disease Patients With Motor Fluctuations
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None